COYA vs SCHW · rev $7.9M vs P/E 19, rev $13.55B
Coya Therapeutics, Inc. Common Stock (COYA) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
COYA currently screens at market cap $118.0M. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the COYA and SCHW stock pages for the full models.
Not investment advice.